Quick facts
- An eye patch is not one product. The word covers an adhesive occlusion patch, an eye pad dressing built from gauze and tape, a rigid eye shield, and a conformer placed after surgery.
- Canada: a medical device intended to contact the surface of the eye is an invasive device under the Medical Devices Regulations, and a Class I device is placed on the market through an establishment licence rather than a device licence.
- United States: the same pad or shield is a Class I device, and Class I devices are generally exempt from premarket notification under 21 CFR 880 and 886.
- Occlusion therapy is a prescription decision, not a catalogue decision. The dose is set by the treating clinician, and the eye care team reviews it as the child's vision changes.
- Whichever patch a clinic uses, the dressing itself is a two-part build: an absorbent sterile gauze pad held in place by a hypoallergenic cloth medical tape.
An eye patch is a device used to cover one eye, and the way it is regulated, dosed and stocked is different in Canada and the United States. Optometrists, ophthalmology offices and paediatric practices buy patches and pad dressings for occlusion therapy, post-operative protection and simple wound cover, and each of those uses carries its own rulebook. Two clinics holding what looks like the same adhesive patch can sit under different market-authorisation pathways, different reimbursement codes and different dressing-build practices.
What types of eye patch are there, and what is each one for?
The single word hides four products with four different jobs. Buying the wrong one is the most common ordering error, because they look similar on a shelf.
Adhesive occlusion patch. A soft patch with an adhesive backing, applied directly over the closed eyelid. Its job is to block vision, not to absorb fluid. Adhesive patches are the usual format for occlusion of a sound eye in amblyopia therapy.
Eye pad dressing. A folded gauze pad secured with tape. Its job is to absorb, cushion and protect. This is the classic post-procedure dressing, and it is assembled chairside rather than bought as a finished unit.
Rigid eye shield. A shaped plastic or metal cover that stands off the eye. Its job is protection without pressure, typically overnight after surgery, and it is reused or disposed of according to the facility's policy.
Conformer. A shaped shell placed in the socket after enucleation or evisceration to hold the fornices open. It is a prosthetic-adjacent device, not a dressing.
| Item | Main job | Typical setting | Contacts the eye surface? |
|---|---|---|---|
| Adhesive occlusion patch | Blocks vision | Paediatric amblyopia therapy | Yes, via closed lid skin |
| Eye pad dressing (gauze + tape) | Absorbs, cushions, protects | Post-procedure, minor injury | Yes, via closed lid |
| Rigid eye shield | Mechanical protection | Overnight post-operative | No, stands off the eye |
| Conformer | Maintains socket form | Post-enucleation | Yes, inside the socket |
The table matters for procurement because only some of these are "patches" in a supplier catalogue, and the classification of each one has regulatory consequences.
Is an eye patch regulated the same way in Canada and the US?
No. The word patch does not decide the pathway; the intended contact with the eye surface does.
In Canada, the Medical Devices Regulations (SOR/98-282) define an invasive device as a device "intended to come into contact with the surface of the eye or penetrate the body, either through a body orifice or through the body surface." A pad or shield that rests against the closed lid is written to contact the eye surface, so it does not sit outside the framework. The same regulations set out the market pathway by class: a Class I device is placed on the market through an application under section 45 for an establishment licence that authorises the holder to sell or import the device, while a Class II, III or IV device needs an application under section 32 for a device licence for the device itself.
For a Canadian clinic, that has a practical consequence. The institution does not license the patch; the person who imports or sells it must hold the establishment licence. When a clinic buys a patch through a Canadian distributor, the licence obligation is upstream. When a clinic imports directly, it is not.
In the United States, eye pads and shields sit inside the ophthalmic device parts of the Code of Federal Regulations. Devices in 21 CFR part 886 are classified by intended use, and most Class I entries are exempt from premarket notification, which means a cleared 510(k) is not the usual route. The FDA product classification database and the device registration and listing database are the public records a US buyer can check.
| Item | Canada | United States |
|---|---|---|
| Governing instrument | Medical Devices Regulations, SOR/98-282 | 21 CFR parts 880 and 886 |
| Definition hook | Invasive device covers contact with the surface of the eye | Classified by intended use |
| Class I market pathway | Establishment licence under section 45 | Generally exempt from premarket notification |
| Class II-IV market pathway | Device licence under section 32 | Premarket notification, typically 510(k) |
| Public record | Health Canada establishment licence register | FDA registration and listing database |
| Clinic obligation | Buy through a licensed seller and keep records | Verify the establishment is registered |
A Canadian buyer cannot assume that a US catalogue listing means the item is cleared, and a US buyer cannot assume a Canadian listing means the seller holds an establishment licence. The check is different in each country and both are cheap to run.
How does occlusion therapy dosing differ between Canada and the US?
It does not differ by country. It differs by patient, and that is the point.
Occlusion therapy for amblyopia is a prescribed dose of patching hours per day, reviewed at intervals, adjusted as visual acuity responds, and often combined with spectacle correction. The American Academy of Ophthalmology describes amblyopia as reduced vision in one or both eyes caused by abnormal visual experience early in life, and its patching resource sets out patching as one of the treatment options. The American Optometric Association and the American Academy of Pediatrics parent resource describe the same principle for families.
What differs inside a clinic is the supply consequence. If the dose is two hours a day, the clinic hands a family a small number of patches and a reorder card. If the dose is most waking hours, the family may need several patches a day, and a patch that irritates the skin becomes a compliance problem rather than a vision problem.
Two clinical points that are frequently missed at the chair:
- The skin matters as much as the eye. Repeated adhesive removal can leave the periorbital skin angry. A clinician changing the patch format is treating skin tolerance, not vision.
- The patch is not the whole treatment. Occlusion works alongside optical correction and monitoring. A patch supplied without a follow-up interval is an incomplete plan.
What does a Canadian clinic actually stock for an eye pad dressing?
The dressing is a build, and the build has three parts.
The absorbent pad. A sterile gauze pad of appropriate ply and size, folded to sit over the closed lid without abrading it. Twelve-ply gauze is the common choice where the dressing is expected to hold for a shift.
The securing tape. A hypoallergenic paper or cloth medical tape that holds the pad without pulling the skin. Tape width decides how much of the field of view is blocked and how easy the dressing is to remove.
The protective cover. A rigid shield placed over the pad where pressure on the globe must be avoided, for instance overnight after a procedure.
Everything else in the room — gloves, hand hygiene, a waste stream for the used dressing — is standard clinical consumable practice. The pad and tape are the two items that run out first, which is why they belong on a standing order rather than a one-off purchase.
For a practice or a multi-site group, the ordering route matters as much as the item list: case quantities, consistent tape width and a single pad format across chairs reduce the variation that shows up as wasted stock.
Which eye patch type is used after surgery, and what does each one do?
Post-operative protection is where the products are most often confused.
A pressure patch is a gauze pad build designed to apply gentle, even pressure over a closed lid. It is a dressing, made chairside, and its performance depends on how the pad is folded and how the tape is tensioned.
A rigid shield stands off the eye and protects against accidental rubbing, most often during sleep. It is not a pressure dressing and should not be used as one.
A conformer is not a dressing at all. It is placed inside the socket to maintain the fornices after removal of the globe, and it is managed as part of prosthetic fitting rather than as a wound cover.
Getting these three right is a documentation issue as much as a clinical one. If a chart says "patch" and the room stocked only shields, the dressing that actually went on the eye is unknown, and a post-operative review has nothing to check against.
Sources
- Medical Devices Regulations, SOR/98-282 (invasive device definition; sections 32 and 45)
- 21 CFR part 886, Ophthalmic devices
- FDA, Medical device classification database
- FDA, Device registration and listing database
- FDA, Premarket notification 510(k) database
- American Academy of Ophthalmology, Amblyopia
- American Academy of Ophthalmology, Patching
- American Optometric Association, Amblyopia
- College of Optometrists of Ontario, resources for optometrists
- StatPearls, Amblyopia (NCBI Bookshelf)
- WHO, Blindness and visual impairment fact sheet
- International Agency for the Prevention of Blindness, Vision Atlas
- College of Optometrists of Ontario, Standards of Practice
- College of Optometrists of Ontario, Infection control
- Canadian Association of Optometrists, Eye health library
- American Academy of Ophthalmology, Infection control in the eye clinic
- WHO, Trachoma fact sheet
Ordering for a clinic, clinic group or care home? Wholesale and multi-site ordering covers account setup and case pricing, and the B2B wholesale collection lists the lines stocked for institutional buyers. Sites that also run an in-house sterilizer can start with the biological indicator 5-pack trial.
Related reading
- Eye wash stations: ANSI Z358.1 and what an Ontario clinic must document
- Choosing examination gloves for eye clinics: nitrile, fit and change frequency
- Building a clinic consumables list that survives an inspection
Frequently Asked Questions
What is an eye patch used for?
An eye patch covers one eye. It is used to block vision in amblyopia therapy, to absorb and cushion a dressing after a procedure or minor injury, and to protect the eye mechanically. Those are three different products with three different jobs, and the intended use decides which regulatory class applies.
Are eye patches regulated differently in Canada and the US?
Yes. In Canada the Medical Devices Regulations treat a device intended to contact the surface of the eye as an invasive device, and a Class I device is placed on the market through an establishment licence under section 45, while Class II to IV devices need a device licence under section 32. In the United States the same pad or shield is classified inside 21 CFR part 886, and most Class I entries are exempt from premarket notification.
Does a Canadian clinic need a licence to buy eye patches?
The clinic is not the licence holder. The obligation attaches to the person who imports or sells the device, who must hold the establishment licence for a Class I device. A clinic buying through a Canadian distributor is buying from a licensed seller, and it keeps its own purchasing records as part of device traceability.
How many hours a day should an eye patch be worn?
That is a prescription decision. Occlusion therapy is dosed by hours per day and reviewed at intervals by the treating eye care professional as visual acuity responds, usually alongside spectacle correction.
What is the difference between an eye patch and an eye pad?
An adhesive patch blocks vision and is applied over the closed eyelid. An eye pad is an absorbent dressing, normally a folded gauze pad secured with tape, used to absorb, cushion and protect. A clinic may stock both, and the chart should name which one was used.
Can a rigid eye shield be used as a pressure dressing?
No. A shield stands off the eye to prevent rubbing, while a pressure dressing is a gauze build that applies gentle, even pressure over a closed lid. Substituting one for the other changes the treatment and leaves the record inaccurate.
What supplies are needed to build an eye pad dressing?
Three items: an absorbent gauze pad of the right ply and size, a hypoallergenic tape to secure it without pulling the skin, and a rigid shield where pressure on the globe must be avoided. Gloves and a defined waste stream for the used dressing complete the set.
CliniEco Medical supplies sterile gauze, medical tape, examination gloves and the wider clinic consumable lines described in this article. Health Canada MDEL #35334. This article is written for clinic, optometry and procurement professionals and is not clinical guidance; occlusion dosing and dressing selection belong to the treating clinician.
0 comments